跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 527 条关于
“Glycogen synthase”
全部
527
临床试验
278
药物
81
机构
4
资讯
164
去年
Elraglusib Shows Promise for Advanced Salivary Gland Carcinoma in Upcoming AACR Presentation
去年
Aro Biotherapeutics' ABX1100 Receives FDA IND Clearance for Late-Onset Pompe Disease Trial
去年
Pompe Disease Pipeline Shows Promise with Novel Therapies in Development
去年
Actuate Therapeutics and Lantern Pharma Collaborate on AI-Driven Elraglusib Development
6年前
Overcoming Osimertinib Resistance in EGFR-Mutant NSCLC Through GSK-3 Inhibition
去年
Advancements in Pompe Disease Treatment: A Pipeline Review
6个月前
Shionogi Initiates Phase 2 Trial for First Oral Substrate Reduction Therapy in Late-Onset Pompe Disease
11个月前
Aro Biotherapeutics Completes Enrollment in Phase 1b Trial of Novel siRNA Therapy for Late-Onset Pompe Disease
2年前
Elraglusib Receives FDA Orphan Drug Designation for Soft Tissue Sarcoma
去年
Elraglusib Receives FDA Rare Pediatric Disease Designation for Ewing Sarcoma
第 1 页,共 17 页
上一页
下一页